BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25695999)

  • 1. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.
    Fredman G; Kamaly N; Spolitu S; Milton J; Ghorpade D; Chiasson R; Kuriakose G; Perretti M; Farokzhad O; Tabas I
    Sci Transl Med; 2015 Feb; 7(275):275ra20. PubMed ID: 25695999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment.
    Drechsler M; de Jong R; Rossaint J; Viola JR; Leoni G; Wang JM; Grommes J; Hinkel R; Kupatt C; Weber C; Döring Y; Zarbock A; Soehnlein O
    Circ Res; 2015 Feb; 116(5):827-35. PubMed ID: 25520364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.
    Kamaly N; Fredman G; Subramanian M; Gadde S; Pesic A; Cheung L; Fayad ZA; Langer R; Tabas I; Farokhzad OC
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6506-11. PubMed ID: 23533277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability.
    Petri MH; Laguna-Fernández A; Gonzalez-Diez M; Paulsson-Berne G; Hansson GK; Bäck M
    Cardiovasc Res; 2015 Jan; 105(1):65-74. PubMed ID: 25341894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (Re)solving atherosclerosis.
    Soehnlein O
    Sci Transl Med; 2015 Feb; 7(275):275fs7. PubMed ID: 25695998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice.
    Trentin PG; Ferreira TP; Arantes AC; Ciambarella BT; Cordeiro RS; Flower RJ; Perretti M; Martins MA; Silva PM
    Br J Pharmacol; 2015 Jun; 172(12):3058-71. PubMed ID: 25659822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis.
    Rüger M; Kipp E; Schubert N; Schröder N; Pufe T; Stope MB; Kipp M; Blume C; Tauber SC; Brandenburg LO
    J Neuroinflammation; 2020 Oct; 17(1):325. PubMed ID: 33121515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr
    Yu M; Amengual J; Menon A; Kamaly N; Zhou F; Xu X; Saw PE; Lee SJ; Si K; Ortega CA; Choi WI; Lee IH; Bdour Y; Shi J; Mahmoudi M; Jon S; Fisher EA; Farokhzad OC
    Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28730752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
    Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
    J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ac2-26-Nanoparticles Induce Resolution of Intestinal Inflammation and Anastomotic Healing via Inhibition of NF-κB Signaling in a Model of Perioperative Colitis.
    Reischl S; Lee JH; Miltschitzky JRE; Vieregge V; Walter RL; Twardy V; Kasajima A; Friess H; Kamaly N; Neumann PA
    Inflamm Bowel Dis; 2021 Aug; 27(9):1379-1393. PubMed ID: 33512505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A1 Mimetic Peptide Ac
    Oliveira MP; Prates J; Gimenes AD; Correa SG; Oliani SM
    Front Immunol; 2021; 12():689484. PubMed ID: 34557187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
    Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
    J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.
    Dufton N; Hannon R; Brancaleone V; Dalli J; Patel HB; Gray M; D'Acquisto F; Buckingham JC; Perretti M; Flower RJ
    J Immunol; 2010 Mar; 184(5):2611-2619. PubMed ID: 20107188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
    Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
    FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet.
    Kusters DH; Chatrou ML; Willems BA; De Saint-Hubert M; Bauwens M; van der Vorst E; Bena S; Biessen EA; Perretti M; Schurgers LJ; Reutelingsperger CP
    PLoS One; 2015; 10(6):e0130484. PubMed ID: 26090792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
    Hayhoe RP; Kamal AM; Solito E; Flower RJ; Cooper D; Perretti M
    Blood; 2006 Mar; 107(5):2123-30. PubMed ID: 16278303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin A1 Mimetic Peptide and Piperlongumine: Anti-Inflammatory Profiles in Endotoxin-Induced Uveitis.
    Girol AP; de Freitas Zanon C; Caruso ÍP; de Souza Costa S; Souza HR; Cornélio ML; Oliani SM
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.